Evaluation of drug effects on Toxoplasma gondii nuclear and plastid DNA replication using real-time PCR

Parasitology Research

Volumn 106, Issue 5, 2010, Pages 1257-1262

  Zhao, Qing ^a   Zhang, Ming ^a   Hong, Lingxian ^a   Zhou, Kefu ^a   Lin, Yuguang ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSPIRAMYCIN; ARTEMETHER; AZITHROMYCIN; CELL NUCLEUS DNA; CIPROFLOXACIN; CLINDAMYCIN; PROTOZOAL DNA; SULFADIAZINE;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA REPLICATION; DRUG EFFICACY; GENE DOSAGE; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE DEVELOPMENT; PRIORITY JOURNAL; PROTOZOAL GENETICS; REAL TIME POLYMERASE CHAIN REACTION; TACHYZOITE; TOXOPLASMA GONDII;

ANTIPROTOZOAL AGENTS; CELL NUCLEUS; DNA PRIMERS; DNA REPLICATION; DNA, PROTOZOAN; HELA CELLS; HUMANS; PLASTIDS; POLYMERASE CHAIN REACTION; TOXOPLASMA;

PROTOZOA; TOXOPLASMA GONDII;

EID: 77953286167     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-010-1792-3     Document Type: Article

References (35)

1. Ajioka JW, Morrissette NS (2009) A century of Toxoplasma research. Int J Parasitol 39:859-860
2. Araujo FG, Shepard RM, Remington JS (1991) In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 10:519-524
3. Beckers CJ, Roos DS, Donald RG, Luft BJ, Schwab JC, Cao Y, Joiner KA (1995) Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics. J Clin Invest 95:367-376
4. Blais J, Garneau V, Chamberland S (1993) Inhibition of Toxoplasma gondii protein synthesis by azithromycin. Antimicrob Agents Chemother 37:1701-1703
5. Boothroyd JC (2009) Toxoplasma gondii: 25 years and 25 major advances for the field. Int J Parasitol 39:935-946
6. Borst P, Overdulve JP, Weijers PJ, Fase-Fowler F, Van den Berg M (1984) DNA circles with cruciforms from isospora (Toxoplasma) gondii. Biochim Biophys Acta 781:100-111
7. Buckley SM (1973) Survival of Toxoplasma gondii in mosquito cell lines and establishment of continuous infection in vero cell cultures. Exp Parasitol 33:23-26
8. Chan YH, Kwok ACM, Tsang JSH, Wong JTY (2006) Alveolata histone-like proteins have different evolutionary origins. J Evolution Biol 19:1717-1721
9. Contini C, Seraceni S, Cultrera R, Incorvaia C, Sebastiani A, Picot S (2005) Evaluation of a real-time pcr-based assay using the lightcycler system for detection of Toxoplasma gondii bradyzoite genes in blood specimens from patients with toxoplasmic retinochoroiditis. Int J Parasitol 35:75-283
10. Dunay IR, Heimesaat MM, Bushrab FN, Muller RH, Stocker H, Arasteh K, Kurowski M, Fitzner R, Borner K, Liesenfeld O (2004) Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Antimicrob Agents Chemother 48:4848-4854
11. Edvinsson B, Lappalainen M, Evengard B (2006) Real-time pcr targeting a 529-bp repeat element for diagnosis of toxoplasmosis. Clin Microbiol Infect 12:131-136
12. Evans R, Chatterton JMW, Ashburn D, Joss AWL, Ho-Yen O (1999) Cell-culture system for continuous production of Toxoplasma gondii tachyzoites. Eur J Clin Microbiol Infect Dis 18:879-884
13. Fichera ME, Roos DS (1997) A plastid organelle as a drug target in apicomplexan parasites. Nature 390:407-409
14. Fleige T, Fischer K, Ferguson DJ, Gross U, Bohne W (2007) Carbohydrate metabolism in the Toxoplasma gondii apicoplast: Localization of three glycolytic isoenzymes, the single pyruvate dehydrogenase complex, and a plastid phosphate translocator. Eukaryot Cell 6:984-996
15. Gjerdrum LM, Sorensen BS, Kjeldsen E, Sorensen FB, Nexo E, Hamilton-Dutoit S (2004) Real-time quantitative pcr of micro-dissected paraffin-embedded breast carcinoma: an alternative method for her-2/neu analysis. J Mol Diagn 6:42-51
16. Gleeson MT (2000) The plastid in apicomplexa: what use is it? Int J Parasitol 30:1053-1070
17. Goodman CD, McFadden GI (2007) Fatty acid biosynthesis as a drug target in apicomplexan parasites. Curr Drug Targets 8:15-30
18. Hackstein JH, Mackenstedt U, Mehlhorn H, Meijerink JP, Schubert H, Leunissen JA (1995) Parasitic apicomplexans harbor a chlorophyll a-d1 complex, the potential target for therapeutic triazines. Parasitol Res 81:207-216
19. Jeffries AC, Johnson AM (1996) The growing importance of the plastid-like DNAs of the apicomplexa. Int J Parasitol 26:1139-1150
20. Ke OY, Krug EC, Marr JJ, Berens RL (1990) Inhibition of growth of Toxoplasma gondii by qinghaosu and derivatives. Antimicrob Agents Chemother 34:1961-1965
21. Kohler S (2005) Multi-membrane-bound structures of apicomplexa: I. The architecture of the Toxoplasma gondii apicoplast. Parasitol Res 96:258-272
22. Kohler S, Delwiche CF, Denny PW, Tilney LG, Webster P, Wilson RJM, Palmer JD, Roos DS (1997) A plastid of probable green algal origin in apicomplexan parasites. Science 275:1485-1489
23. Lin MH, Chen TC, Kuo TT, Tseng CC, Tseng CP (2000) Real-time PCR for quantitative detection of Toxoplasma gondii. J Clin Microbiol 38:4121-4125
24. Liu Y, Zhang YH, Li Z, Yao XM (1997) Experimental study on the effect of artemether against Toxoplasma gondii in vitro. Chin J Parasitol Parasitic Dis 15:366-369
25. Matsuzaki M, Kikuchi T, Kita K, Kojima S, Kuroiwa T (2001) Large amounts of apicoplast nucleoid DNA and its segregation in Toxoplasma gondii. Protoplasma 218:180-191
26. Pfefferkorn ER, Borotz SE (1994) Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin. Antimicrob Agents Chemother 38:31-37
27. Ramya TN, Mishra S, Karmodiya K, Surolia N, Surolia A (2007) Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in plasmodium falciparum. Antimicrob Agents Chemother 51:307-316
28. Rasmussen R (2001) Quantification on the lightcycler. In: Meuer S, Wittwer C, Nakagawara K (eds) Rapid cycle real-time PCR, methods and applications. Springer Press, Heidelberg, pp 21-34
29. Roos DS, Donald RGK, Morrissette NS, Moulton ALC (1994) Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii. Methods Cell Biol 45:27-63
30. Roos DS, Crawford MJ, Donald RG, Kissinger JC, Klimczak LJ, Striepen B (1999) Origin, targeting, and function of the apicomplexan plastid. Curr Opin Microbiol 2:426-432
31. Sambrook J, Russell D (2001) Molecular cloning: a laboratory manual, 3rd edn. CSHL Press, Cold Spring Harbour, New York, pp 1.116-1.118
32. Schoondermark-van de Ven E, Vree T, Melchers W, Camps W, Galama J (1995) In vitro effects of sulfadiazine and its metabolites alone and in combination with pyrimethamine on Toxoplasma gondii. Antimicrob Agents Chemother 39:763-765
33. Sonda S, Hehl AB (2006) Lipid biology of apicomplexa: perspectives for new drug targets, particularly for Toxoplasma gondii. Trends Parasitol 22:41-47
34. Switaj K, Master A, Skrzypczak M, Zaborowski P (2005) Recent trends in molecular diagnostics for Toxoplasma gondii infections. Clin Microbiol Infec 11:170-176
35. Wu L, Chen SX, Jiang XG, Cao JP (2009) Toxoplasma gondii: a simple real time PCR assay to quantify the proliferation of apicoplast. Exp Parasitol 123:384-387